-
Most Popular
Search Results
240 results for ddic
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
New ETFs Beat the Yield Drum to Death
Besides the many income-based funds that launched last week, a technical fund and two Aussie dollar ETFs also debuted. Find out about them here.
Sprint Stock: 1 Pro, 5 Cons
Sprint has a host of challenges, including fierce competition and the expense of rolling out a 4G LTE network. But it has one thing going…
Will Google’s Chrome Chip Away at Microsoft’s Veneer?
In case you missed it, there has been a major shift in the tectonic plates of the software war brewing between Microsoft (MSFT) and Google…
The 5 Best Funds to Fight Inflation
Think the Federal Reserve will swoop in at every sign of small inflation? Maybe, but it’s no guarantee. Prudent investors should always have a few…
Watch Out Whole Foods! Fresh Thyme Eyes 54 Stores in 6 Years
Fresh Thyme Farmer’s Market, a produce-focused grocery chain, plans to open 54 stores in the next six years.
BDAT: New PureFunds ETF Capitalizes on Big Data
PureFunds just might capitalize on big data through PureFunds ISE Big Data ETF (BDAT) the way it thrived on cybersecurity with HACK.
7 Biotechnology Stocks to Sell Now
The ratings of seven biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
7 Biotechnology Stocks to Sell Now
This week, the overall grades of seven Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
7 Biotechnology Stocks to Sell Now
This week, the overall grades of seven Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
7 Biotechnology Stocks to Sell Now
This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
7 Biotechnology Stocks to Sell Now
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
What to Expect From Google’s ‘Future of Gaming’ Event
With its Mar. 19 press conference at GDC 2019, expect Google to announce Project Yeti details as it aims to cash in on video gaming.
CIIG Merger Corporation Is an Easy Way to Make Quick Money
CIIC stock is probably going to rise up to its IPO. Investors can make money there and the company could be a long-term winner as…
8 – 10 of 240 results
